Failure to thrive
Basic details
Preferred term: Failure to thrive
Alt. terms: FTT | Undergrowth | Poor weight gain | Weight faltering | Postnatal failure to thrive | Faltering weight
HPO term: Failure to thrive
HPO code: HP:0001508
GenIA ID: 504
Last updated on: 2021-12-10 17:55:48
Cross ref. with other ontologies
NCIT: C85038
MESH: D005183
EFO: -
OAE:0000938
SNOMEDCT: -
ICD10: -
Description
It refers to a child whose physical growth is substantially below the norm. Although there is no clear consensus on the exact definition of FTT, it is usually diagnoses in a child growing below the 3rd percentile or in a child whose decreased growth has cross two major growth percentiles (for example, from above the 75th percentile to below the 25th percentile).
Hierarchical classification
PARENT terms
TERM
Failure to thrive
Reported patients added to GenIA DB
| SubjectID | Sex | Fam.ID | Age* | Population | MatchedTerm | Diagnosis | Reference & Pub.codes |
|---|---|---|---|---|---|---|---|
| 101260 | M | 212144 | - | Iranian | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:22608502 [Fam.C:II.1(P4)]; PMID:29528757 [Case 7]; PMID:26707784 [P4]; PMID:26993986 [F6]; PMID:28512785 [P14] |
| 101286 | F | 212146 | 18 | Saudi | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:22721650 [Fam.VI:5:V.3]; PMID:25468195 [Fam.C:II.3(P4)]; PMID:26707784 [P8] |
| 101379 | M | 212163 | 2 | Iranian | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:29461210 [Fam.2:II.2(P3)]; PMID:26707784 [Fam.C:IV.4(P25)]; PMID:26993986 [F4]; PMID:28512785 [P10] |
| 101399 | F | 210189 |
- | German | Failure to thrive | Adenosine deaminase 2 deficiency | PMID:28493328 [P6]; PMID:26922074 [Fam.Index:II.1(sister1)] |
| 101416 | M | 212169 | 5 | Turkish | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:27146671 [Patient(II.1)] |
| 101435 | F | 212171 | 3 | Lebanese | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:26707784 [P29(II.1)] |
| 101597 | M | 212618 |
0 | Jewish | Failure to thrive | ARPC1B deficiency | PMID:29127144 [Fam.P1:II.10(P2)]; PMID:30254128 [P7]; PMID:35767111 [P6] |
| 101601 | M | 212619 |
10 | Italian | Failure to thrive | ARPC1B deficiency | PMID:30254128 [Fam.A:II.1(P1)]; PMID:30771411 [P2]; PMID:35967303 [Pt2]; PMID:35767111 [P2] |
| 101753 | M | 210024 | - | Japanese | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:26768763 [Fam.553:II.1(P10)] |
| 101754 | M | 210024 | - | Japanese | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:26768763 [Fam.553:II.2(P11)] |
| 101763 | M | 210030 | 3 | North American | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:26768763 [Fam.629:P18]; PMID:26206937 [P8] |
| 101869 | M | 210076 | - | Failure to thrive | Immunodeficiency 31C | PMID:34390440 [CMC08] | |
| 101930 | M | 210100 | - | Algerian | Failure to thrive | Immunodeficiency 31C | PMID:34390440 [CMC13] |
| 102065 | M | 214285 | - | Egyptian | Failure to thrive | Hyper-IgE recurrent infection syndrome 2 | PMID:34390440 [HIES23] |
| 102119 | M | 214343 | - | Egyptian | Failure to thrive | Hyper-IgE recurrent infection syndrome 2 | PMID:34390440 [HIES15] |
| 102143 | M | 214416 | - | Slovenian | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:28720148 [Patient] |
| 102245 | M | 214924 |
14 | Afghanistani | Failure to thrive | ARPC1B deficiency | PMID:33679784 [Fam.II-6:II.1(II-1)] |
| 102247 | F | 214924 |
10 | Afghanistani | Failure to thrive | ARPC1B deficiency | PMID:33679784 [Fam.II-6:II.3(II-3)] |
| 102250 | M | 214924 |
1 | Afghanistani | Failure to thrive | ARPC1B deficiency | PMID:33679784 [II-6(II.6)]; PMID:35767111 [P7] |
| 102260 | F | 214926 |
- | Mexican | Failure to thrive | ARPC1B deficiency | PMID:32683750 [Fam.case:II.2(sister)]; PMID:36708766 [Fam.A:II.2(P1)] |
| 102262 | F | 214927 |
- | Japanese | Failure to thrive | OAS1 immunodeficiency | PMID:29455859 [Fam.C:II.1]; PMID:34145065 [P5(II.1)]; PMID:29185156 [P2] |
| 102269 | M | 214928 |
0 | Japanese | Failure to thrive | OAS1 immunodeficiency | PMID:29455859 [Fam.A:II.3] |
| 102274 | F | 214929 |
- | German | Failure to thrive | OAS1 immunodeficiency | PMID:34145065 [P1(II.2)] |
| 102277 | M | 214930 |
- | North American | Failure to thrive | OAS1 immunodeficiency | PMID:34145065 [P2(II.1)] |
| 102281 | M | 214931 |
- | North American | Failure to thrive | OAS1 immunodeficiency | PMID:34145065 [P3(II.2)] |
| 102285 | F | 214932 |
- | North American | Failure to thrive | OAS1 immunodeficiency | PMID:34145065 [P4(II.2)] |
| 102398 | F | 214944 |
0 | Saudi | Failure to thrive | Otofaciocervical syndrome 2 | PMID:32111619 [Fam.C:V.2(P4)] |
| 102419 | M | 214948 |
- | Irish Traveller | Failure to thrive | Immunodeficiency 54 | PMID:16532402 [Fam.A:IV.8(P1)]; PMID:22354167 [Fam.A:IV.8(P1.1)] |
| 102523 | M | 214965 |
- | Irish Traveller | Failure to thrive | Immunodeficiency 54 | PMID:22354170 [Fam.C:II.1(P1)] |
| 102572 | F | 214967 |
- | Irish Traveller | Failure to thrive | Immunodeficiency 54 | PMID:22354170 [Fam.B:II.12(P8)] |
| 102573 | M | 214967 |
- | Irish Traveller | Failure to thrive | Immunodeficiency 54 | PMID:22354170 [Fam.B:II.13(P7)] |
| 102621 | F | 214968 |
- | Irish Traveller | Failure to thrive | Immunodeficiency 54 | PMID:22354170 [Fam.A:V.2(P3)] |
| 102625 | M | 214968 |
- | Irish Traveller | Failure to thrive | Immunodeficiency 54 | PMID:22354170 [Fam.A:V.6(P4)] |
| 102653 | F | 214977 |
- | Irish Traveller | Failure to thrive | Immunodeficiency 54 | PMID:22499342 [Fam.1:III.11(III:11)] |
| 102711 | F | 214977 |
- | Irish Traveller | Failure to thrive | Immunodeficiency 54 | PMID:22499342 [Fam.1:IV.4(IV:4)] |
| 102716 | M | 214977 |
- | Irish Traveller | Failure to thrive | Immunodeficiency 54 | PMID:22499342 [Fam.1:IV.9(IV:9)] |
| 102717 | F | 214977 |
- | Irish Traveller | Failure to thrive | Immunodeficiency 54 | PMID:22499342 [Fam.1:IV.10(IV:10)] |
| 102719 | F | 214981 |
0 | Canadian | Failure to thrive in infancy | Autoinflammation, immune dysregulation, and eosinophilia | PMID:28111307 [Fam.1:II.2(Patient)]; PMID:36546480 [Fam.1:II.2(II-2)] |
| 102729 | M | 214981 |
0,0 | Canadian | Decreased body weight,Failure to thrive | Autoinflammation, immune dysregulation, and eosinophilia | PMID:28111307 [Fam.1:III.1]; PMID:36546480 [Fam.1:III.1(III-1)] |
| 102730 | M | 214981 |
0,0 | Canadian | Decreased body weight,Failure to thrive | Autoinflammation, immune dysregulation, and eosinophilia | PMID:28111307 [Fam.1:III.2]; PMID:36546480 [Fam.1:III.2(III-2)] |
| 102735 | F | 214983 |
- | North American | Decreased body weight | Autoinflammation, immune dysregulation, and eosinophilia | PMID:32750333 [Patient(II.2)] |
| 102739 | F | 214984 |
0 | Japanese | Decreased body weight | Autoinflammation, immune dysregulation, and eosinophilia | PMID:35046931 [Patient(II.1)] |
| 102819 | M | 214995 | 0 | Failure to thrive | Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency | PMID:14523047 [Patient(II.1)] | |
| 102865 | F | 214996 |
0 | Italian | Failure to thrive | ARPC1B deficiency | Hartnup disease | PMID:35967303 [PtII-1(II.1)]; PMID:35967303 [PtII-1(II.1)] |
| 102871 | F | 215001 |
0 | Italian | Failure to thrive | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:8911612 [A.D.]; PMID:10206641 [Patient(II.2)]; PMID:33464451 [P1(II.2)]; PMID:28077132 [Fam.1:II.2(P1)] |
| 102900 | F | 215007 |
- | Turkish | Failure to thrive | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:30903456 [Fam.P1:II.2(P2)]; PMID:33464451 [Fam.P12:II.2(P13)]; PMID:37419334 [P13(27)] |
| 102933 | M | 215034 | - | Failure to thrive | T-cell lymphopenia with or without nail dystrophy, AD | PMID:31447097 [P22]; PMID:37419334 [P22(22)] | |
| 102934 | F | 215035 |
- | Caucasian | Failure to thrive | T-cell lymphopenia with or without nail dystrophy, AD | PMID:31447097 [P23]; PMID:33464451 [P14(III.1)]; PMID:37419334 [P23(22)] |
| 102935 | M | 215035 |
- | Caucasian | Failure to thrive | T-cell lymphopenia with or without nail dystrophy, AD | PMID:31447097 [P24]; PMID:33464451 [Fam.P14:III.2(P15)]; PMID:37419334 [P15(27)] |
| 102962 | F | 215058 |
0 | North American | Failure to thrive in infancy | T-cell immunodeficiency with thymic aplasia | PMID:31566583 [P1(II.1)]; PMID:37419334 [P1] |
| 103067 | F | 215097 |
0 | Finnish | Failure to thrive | Seizures, cortical blindness, microcephaly syndrome | PMID:33662367 [Fam.F3:II.3(P4)] |
| 103116 | F | 215101 |
- | Saudi | Decreased body weight | Seizures, cortical blindness, microcephaly syndrome | PMID:24781755 [P1(IV.4)] |
| 103128 | F | 215101 |
- | Saudi | Decreased body weight | Seizures, cortical blindness, microcephaly syndrome | PMID:24781755 [Fam.P1:IV.5] |
| 103129 | F | 215101 |
- | Saudi | Decreased body weight | Seizures, cortical blindness, microcephaly syndrome | PMID:24781755 [Fam.P1:IV.6] |
| 103281 | F | 215111 |
1 | Chinese (China) | Decreased body weight | Immunodeficiency 82 with systemic inflammation | PMID:33782605 [Fam.1:II.2(P1)] |
| 103466 | M | 215133 |
- | Irish Traveller | Failure to thrive | Immunodeficiency 54 | PMID:22499342 [Fam.3:II.1(II:1)] |
| 103538 | F | 215155 |
1 | Mexican | Failure to thrive | ARPC1B deficiency | PMID:36708766 [Fam.B:II.2(P3)] |
| 103541 | M | 215155 |
- | Mexican | Failure to thrive | ARPC1B deficiency | PMID:36708766 [Fam.B:II.1(P4)] |
| 103877 | F | 215266 |
1 | Finnish | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:25038750 [P2]; PMID:25349174 [Fam.2:II.2(Patient 2)]; PMID:35677041 [Pt2] |
| 103997 | M | 215318 |
- | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:25359994 [P1]; PMID:30092289 [P16] | |
| 104001 | F | 215322 |
1 | North American | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:25359994 [P5]; PMID:32392079 [P3]; PMID:30092289 [P15]; PMID:35677041 [Pt3]; PMID:33651637 [Patient 1] |
| 104148 | M | 215392 |
- | Syrian | Failure to thrive in infancy | Hyper-IgE recurrent infection syndrome 1 | PMID:34137790 [Fam.A:III.5(P1)] |
| 104226 | F | 215419 |
1 | Spanish | Failure to thrive | Tubulointerstitial kidney disease type 5 | PMID:33185949 [case(II.1)] |
| 104268 | M | 215444 |
-,17 | Ashkenazi Jewish | Decreased body weight,Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:28153428 [Patient(II.2)] |
| 104398 | M | 215522 |
- | Czech | Failure to thrive | Systemic early-onset autoinflammation, vasculitis and hepatopathy | PMID:36932076 [P3(II.1)] |
| 104410 | M | 215525 |
- | Japanese | Failure to thrive | Early-onset atopic inflammation | PMID:36538978 [Patient(II.2)] |
| 104554 | M | 215551 |
- | Pakistani | Failure to thrive | Autoinflammation, panniculitis, and dermatosis syndrome | PMID:27523608 [Fam.1:V.2(V:2)]; PMID:27559085 [Fam.1:V.2(P1)]; PMID:35587511 [Fam.G:II.2(4)]; PMID:34797715 [P1]; PMID:38914362 [Fam.A:V.2(023)] |
| 104568 | F | 215551 |
0 | Pakistani | Failure to thrive | Autoinflammation, panniculitis, and dermatosis syndrome | PMID:27523608 [Fam.1:IV.3(IV:3)]; PMID:32231246 [IV:3(IV.3)]; PMID:27559085 [Fam.1:IV.1(P4)]; PMID:38914362 [Fam.A:V.6(027)] |
| 104570 | F | 215551 |
- | Pakistani | Failure to thrive | Autoinflammation, panniculitis, and dermatosis syndrome | PMID:27523608 [Fam.1:IV.4(IV:4)]; PMID:27559085 [Fam.1:IV.3(NA)]; PMID:38914362 [Fam.A:V.7(028)] |
| 104575 | F | 215552 |
- | Turkish | Failure to thrive | Autoinflammation, panniculitis, and dermatosis syndrome | PMID:27559085 [Fam.2:II.1(P2)]; PMID:35587511 [Fam.I:II.2(4)]; PMID:34797715 [P2]; PMID:38914362 [Fam.B:II.1(035)] |
| 104580 | F | 215553 |
- | Turkish | Failure to thrive | Autoinflammation, panniculitis, and dermatosis syndrome | PMID:27559085 [Fam.3:II.1(P3)]; PMID:35587511 [Fam.H:II.1(3)]; PMID:34797715 [P3]; PMID:38914362 [Fam.C:II.1(039)] |
| 104607 | M | 215556 |
- | Failure to thrive | X-linked multisystem autoinflammatory disease with immune dysregulation | PMID:37342957 [Fam.A:II.3(P1)] | |
| 104625 | M | 215559 |
- | Failure to thrive | X-linked multisystem autoinflammatory disease with immune dysregulation | PMID:37342957 [Fam.B:II.2(P2)] | |
| 104630 | M | 215560 |
- | Failure to thrive | X-linked multisystem autoinflammatory disease with immune dysregulation | PMID:37342957 [Fam.C:II.2(P3)] | |
| 104639 | F | 215562 | 3 | Iraqi | Failure to thrive | Immunodeficiency 91 and hyperinflammation | PMID:33872655 [Fam.A:II.2(P1.2)] |
| 104642 | F | 215562 | 0 | Iraqi | Failure to thrive | Immunodeficiency 91 and hyperinflammation | PMID:33872655 [Fam.A:II.1(P1.1)] |
| 104864 | F | 215598 |
- | Failure to thrive | Immunodeficiency, common variable, 14 | PMID:33864888 [S125]; PMID:37876937 [Fam.B:II.1(B.1)] | |
| 104926 | M | 215621 | - | Iranian | Failure to thrive | Combined immunodeficiency 39 | PMID:34826259 [Fam.1:II.4(Patient)] |
| 105025 | F | 215626 |
- | French | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:32392079 [P1]; PMID:29590538 [Patient]; PMID:35677041 [Pt8] |
| 105028 | F | 215627 | - | French | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:30299506 [Patient]; PMID:32392079 [P2]; PMID:35677041 [Pt10] |
| 105043 | F | 215630 |
- | Caucasian | Failure to thrive | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:27379089 [P9(II.1)]; PMID:29729943 [Fam.BBB:II.1(BBB.II.1 (131))] |
| 105046 | M | 215632 |
1 | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:28253502 [Fam.1:II.1(Patient 1)] | |
| 105050 | F | 215633 | - | Decreased body weight | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:28253502 [Patient 2] | |
| 105103 | F | 215641 | 5 | South Korean | Failure to thrive | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:26478010 [III.2(III.2)] |
| 105135 | F | 215649 |
- | Moroccan | Failure to thrive | Autoinflammation, panniculitis, and dermatosis syndrome | PMID:38914362 [Fam.M:II.1(107)] |
| 105241 | M | 215673 | - | Kuwaiti | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:27760045 [P3(II.1)] |
| 105272 | M | 215681 | 1 | Saudi | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:28134088 [P1(II.1)] |
| 105351 | M | 215713 | - | Saudi | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:28831385 [PD] |
| 105353 | F | 215715 | 10 | Turkish | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:26686526 [P1] |
| 105355 | M | 215717 | 0 | Caucasian | Failure to thrive in infancy | Immunodeficiency, common variable, 8 | PMID:28197149 [P1(II.1)] |
| 105562 | M | 215805 | 10 | Turkish | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:31026575 [P1]; PMID:31432443 [P4] |
| 105564 | M | 215807 |
0 | Spanish | Failure to thrive | 4q24 deletion syndrome | PMID:29867916 [N227(II.1)]; PMID:150198 [Fam.BK:I.2(291)]; PMID:35784294 [case(II.1)] |
| 105568 | M | 215809 | 0 | Failure to thrive | Activated p110-delta syndrome 1 | PMID:24698326 [Fam.A:II.1(P2)] | |
| 105572 | M | 215811 | - | South Asian | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:32154999 [Patient] |
| 105585 | F | 215818 | 0 | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:33713070 [Case3] | |
| 105629 | M | 215823 | 4,2 | Decreased body weight,Failure to thrive | Immunodeficiency, common variable, 8 | PMID:34368306 [Patient 1] | |
| 105647 | M | 215832 | - | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:34368306 [Patient 3] | |
| 105799 | M | 215881 |
0 | Pakistani | Failure to thrive | Combined immunodeficiency 41 | PMID:32980423 [Fam.1:V.2(1.V.2)]; PMID:150198 [Fam.DS:V.2(506)] |
| 105850 | F | 215891 |
- | Failure to thrive in infancy | Autoinflammation, immune dysregulation, and eosinophilia | PMID:33864888 [S066(II.6)] | |
| 106150 | F | 215955 | - | Turkish | Failure to thrive | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:33464451 [P10] |
| 106320 | M | 215984 | 0 | Failure to thrive | NFKB1 insufficiency | PMID:150198 [Fam.EX:608]; PMID:36105815 [L196V] | |
| 106390 | M | 216005 | - | Decreased body weight | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:32996901 [Patient(II.1)] | |
| 106419 | F | 216013 |
0 | Failure to thrive | T-negative/B-positive SCID type 1 | PMID:7481768 [AP(II.1)] | |
| 106448 | F | 216016 |
- | Japanese | Failure to thrive | Autoinflammation, panniculitis, and dermatosis syndrome 2 | PMID:38914362 [Fam.R:II.1(130)]; PMID:38652464 [Fam.1:II.1(Patient)] |
| 106474 | M | 216027 | - | Egyptian | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:32506362 [P9] |
| 106483 | F | 216036 | - | Egyptian | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:32506362 [P18] |
| 106491 | F | 216044 |
- | Failure to thrive | Immunodeficiency 22 | PMID:22985903 [Fam.1:II.1(patient)] | |
| 106654 | M | 216101 |
- | Syrian | Decreased body weight | Intellectual disability due to EZR deficiency | PMID:25504542 [Fam.MR037:IV.1(IV-1)] |
| 106667 | M | 216101 |
1 | Syrian | Decreased body weight | Intellectual disability due to EZR deficiency | PMID:25504542 [Fam.MR037:IV.3(IV-3)] |
| 106750 | F | 216121 |
0 | Palestinian | Failure to thrive | T-negative/B-positive SCID type 1 | PMID:32921793 [Fam.B:II.1(P1-B)] |
| 106761 | F | 216124 |
1 | Caucasian | Failure to thrive | T-negative/B-positive SCID type 1 | PMID:28916186 [P5]; PMID:31440277 [pt(II.1)] |
| 106787 | M | 216138 | - | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34619682 [P.278] | |
| 106789 | M | 216140 | - | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34619682 [P.282] | |
| 106816 | F | 216162 | - | Failure to thrive | Immunodeficiency, common variable, 8 | PMID:39184709 [Fam.1:II.1(Patient)] | |
| 106956 | M | 216197 | - | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:30092289 [P12] | |
| 106957 | F | 216198 | - | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:30092289 [P13] | |
| 106958 | M | 216199 | - | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:30092289 [P14] | |
| 106959 | M | 216200 | - | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:30092289 [P17]; PMID:35677041 [Pt9] | |
| 107047 | F | 216286 | 1 | Failure to thrive | Activated p110-delta syndrome 1 | PMID:28428270 [P3] | |
| 107096 | F | 216332 | - | Japanese | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:33501615 [P3] |
| 107103 | M | 216335 |
- | Chinese (China) | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:35677041 [Pt1(II.2)] |
| 107149 | M | 216363 | - | Iranian | Failure to thrive | Severe congenital neutropenia 6 | PMID:37120535 [Fam.1:I.3(P1)] |
| 107150 | F | 216363 | 2 | Iranian | Failure to thrive | Severe congenital neutropenia 6 | PMID:37120535 [Fam.1:I.4(P2)] |
| 107156 | F | 216365 |
- | Turkish | Failure to thrive | Hyper-IgE recurrent infection syndrome 2 | PMID:39437980 [Fam.B:II.2(Patient 2)] |
| 107161 | F | 216366 |
- | Sri Lankan Tamil | Failure to thrive | Adenosine deaminase 2 deficiency | PMID:26607704 [P1(II.1)] |
| 107212 | F | 216374 | 1,4 | Arab | Decreased body weight,Failure to thrive | Combined immunodeficiency 37 | PMID:31775018 [Patient] |
| 107225 | M | 216381 |
0 | Vietnamese | Failure to thrive | Hemophagocytic lymphohistiocytosis, familial 5 | PMID:36503158 [Patient(III.3)] |
| 107245 | M | 216394 |
2 | Caucasian | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:30809743 [Fam.2:II.1(Pt#2)] |
| 107252 | M | 216399 |
- | North American | Failure to thrive | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:29378236 [Fam.2:II.2(Patient 2)] |
*Age: age reported at the first known time of manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).